Richardcyoung.com

  • Home
  • Debbie Young
  • Jimmy Buffett
  • Key West
  • Your Survival Guy
  • How We Are Different
  • Paris
  • About Us
    • Foundation Principles
    • Contributors
  • Investing
    • You’ve Read The Last Issue of Intelligence Report, Now What?
  • The Great Reset
  • The Swiss Way
  • My Rifles
  • Dividends and Compounding
  • Your Security
  • Dick Young
  • Dick’s R&B Top 100
  • Liberty & Freedom Map
  • Bank Credit & Money
  • Your Survival Guy’s Super States
  • NNT & Cholesterol
  • Your Health
  • Ron Paul
  • US Treasury Yield Curve: My Favorite Investor Tool
  • Anti-Gun Control
  • Anti-Digital Currency
  • Joel Salatin & Alfie Oakes
  • World Gold Mine Production
  • Fidelity & Wellington Since 1971
  • Hillsdale College
  • Babson College
  • Artificial Intelligence Opposed
  • Contact Us

Does a New Antiviral Covid Drug Do More Harm than Good?

September 28, 2023 By The Editors

Coronavirus COVID-19 infection 3D question mark illustration. Floating pathogen respiratory influenza covid19 corona virus cells.

By Corona Borealis Studio @ Shutterstock.com

What’s been touted as a new Covid “wonderdrug” reportedly may cause the virus to mutate uncontrollably. Emily Craig of The Daily Mail reports:

Molnupiravir, sold under the brand name Lagevrio, works by stopping Covid from growing and spreading in an infected person, keeping virus levels low.

This helps the body’s immune system control the infection, reducing the risk of severe symptoms and hospitalisation.

Clinical trials suggest the drug — which was rolled out to patients in the UK from December 2021 and described as an ‘excellent addition’ to the country’s ‘armoury against Covid’ — halves the risk of being admitted or dying from Covid.

The team, which included scientists from the University of Cambridge, Imperial College London, the University of Liverpool and the University of Cape Town, noted molnupiravir’s effects are a result of it triggering an array of mutations in the virus.

Many of the mutations damage or kill the virus.

What is molnupiravir?

Molnupiravir works by stopping Covid from growing and spreading in an infected person, keeping virus levels low.

This helps the body’s immune system control the infection, reducing the risk of severe symptoms and hospitalisation.

Clinical trials suggest the drug halves the risk of beding admitted or dying from Covid.

It it taken as four capsules twice a day for five days among those who have recently become infected and are vulnerable.

This includes cancer patients, those with Down’s syndrome and liver disease patients.Molnupiravir, taken as four capsules twice a day for five days, has not been linked to any serious side effects, though some patients report suffering from headaches, nausea and feeling dizzy.

In rare cases, it can trigger an allergic reaction.

However, in some patients, the virus is not fully cleared, meaning they can infect others with the molnupiravir-mutated virus.

They examined a family tree of 15million Covid sequences, collected from global databases, to map its mutations over time.

Covid mutates constantly and most have little to no impact on the virus’s properties, such as how transmissible it is or the severity of infection that it triggers.

However, in a study published in the journal Nature, the researchers said they spotted changes to the virus that looked very different to the expected patterns.

These mutations were strongly linked with people who had taken molnupiravir.

The team noted that the frequency of these mutations increased in 2022, which is when the rollout gathered pace.

The unusual changes to the virus were also more common among older people — who are more likely to be given the drug — in countries known to have high molnupiravir use and among samples taken during clinical trials of the drug.

Three in ten of the abnormal mutations seen in England were among those given the drug, according to the researchers.

The team also spotted clusters of odd mutations, suggesting that the tweaked version of the virus had been passed on to others. However, they noted that no variants of concern are linked to the mutations though to be triggered by the drug.

It is difficult to understand whether molnupiravir risks triggering new variants or whether these could risk public health.

Read more here.

If you’re willing to fight for Main Street America, click here to sign up for the Richardcyoung.com free weekly email.

Related Posts

  • THEN AND NOW: Understanding the COVID-19 Vaccine
  • COVID Deaths Unfortunate but Insignificant
  • COVID-19 Ravages Iran
  • VIDEO: Congressman SLAMS Fauci's COVID-19 Coverup
  • Author
  • Recent Posts
The Editors
The Editors
The Editors
Latest posts by The Editors (see all)
  • Russian Black Sea Fleet Decimated - May 6, 2025
  • Houthis Target Israel Again - May 5, 2025
  • What Happens when AI Makes Things Up? - April 24, 2025

Dick Young’s Must Reads

  • The Worst President in American History
  • Tom Brady Is Proof You Shouldn’t Retire if You Still Love Your Work
  • You Need to Seek Some Shelter for When Things Get Ugly
  • Gold/Silver Coins No Longer Allowed in Safe Deposit Boxes
  • The Fed – “Independent” and “Non Political” – Joins The Resistance
  • Who Wants to Depopulate the Earth?
  • The Problem in America
  • Democracy: The Most Dangerous and Insidious Effect of Majority Rule.
  • Boom or Bust: “What Do You Think of Bitcoin?
  • Are You Prepared to Run Out of Water?

Our Most Popular Posts

  • MIA: Progressive Climate Dogma
  • HELP: I’m Caught in the Tariff Crossfire, Part 2
  • JFK's Peace Died with Him
  • Americans Need Spending Cuts, not Tariffs or Taxes
  • Got Cash?
  • Was Mike Waltz Working with Israel to Set Trump Up?
  • Donald Trump and Cryptocurrency Controversy
  • Can States Nullify Federal Laws?
  • DOGE at CMMS: "Where the Big Fraud Is Happening"
  • Houthis Target Israel Again

Compensation was paid to utilize rankings. Click here to read full disclosure.

RSS Youngresearch.com

  • Survive
  • GLE Advances ‘Holy Grail’ of Enrichment
  • Reusable Hypersonic Era Takes Off Again
  • Fusion Milestone: ITER Magnet System Finished
  • More Young Adults Diagnosed with Cancer
  • May RAGE Gauge: Survive
  • US May Ease Global AI Chip Export Limits
  • Energy Dominance: DOE Outlines FY2026 Budget Under Trump Directive
  • Manufacturing Shines Amid Broader U.S. Productivity Decline
  • Ghost Ships on Radar: China’s New Tech Mimics Entire Navy Fleets

RSS Yoursurvivalguy.com

  • Survive
  • Investing Mistakes to Avoid: #1 Y-O-U
  • Mike Rowe Keeping Families Together
  • May RAGE Gauge: Survive
  • Investing Mistakes to Avoid: #2 Tomorrowland
  • Drone Wars: US and China Showcase Next-Gen Microwave Weapons
  • Solving America’s Missile Shortage
  • BUILDING A GO BAG: Taking Action Is Hard
  • “Investors Need to Beat Back This Mighty Foe,” Dick Young
  • Why the Push for Low Rates?

US Treasury Yield Curve: My Favorite Investor Tool

My Key West Garden Office

Your Retirement Life: Traveling the Efficient Frontier

Live a Long Life

Your Survival Guy’s Mt. Rushmore of Investing Legends

“Then One Day the Grandfather was Gone”

Copyright © 2025 | Terms & Conditions | About Us | Dick Young | Archives